Free Trial

Microbix Biosystems (MBX) Competitors

C$0.32
0.00 (0.00%)
(As of 05/31/2024 ET)

MBX vs. BCT, IPA, SVA, ONC, SCYB, COM, NVH, IGX, TH, and PDP

Should you be buying Microbix Biosystems stock or one of its competitors? The main competitors of Microbix Biosystems include BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Sernova (SVA), Oncolytics Biotech (ONC), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), IntelGenx Technologies (IGX), Theratechnologies (TH), and Pediapharm (PDP). These companies are all part of the "biotechnology" industry.

Microbix Biosystems vs.

Microbix Biosystems (TSE:MBX) and BriaCell Therapeutics (CVE:BCT) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations, community ranking and media sentiment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microbix Biosystems
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
BriaCell Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Microbix Biosystems received 30 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. Likewise, 70.71% of users gave Microbix Biosystems an outperform vote while only 70.18% of users gave BriaCell Therapeutics an outperform vote.

CompanyUnderperformOutperform
Microbix BiosystemsOutperform Votes
70
70.71%
Underperform Votes
29
29.29%
BriaCell TherapeuticsOutperform Votes
40
70.18%
Underperform Votes
17
29.82%

In the previous week, Microbix Biosystems' average media sentiment score of 0.00 equaled BriaCell Therapeutics'average media sentiment score.

Company Overall Sentiment
Microbix Biosystems Neutral
BriaCell Therapeutics Neutral

0.4% of Microbix Biosystems shares are held by institutional investors. 14.4% of Microbix Biosystems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Microbix Biosystems has a net margin of 16.57% compared to BriaCell Therapeutics' net margin of 0.00%. Microbix Biosystems' return on equity of 14.66% beat BriaCell Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Microbix Biosystems16.57% 14.66% 1.87%
BriaCell Therapeutics N/A N/A N/A

Microbix Biosystems has higher revenue and earnings than BriaCell Therapeutics. BriaCell Therapeutics is trading at a lower price-to-earnings ratio than Microbix Biosystems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbix BiosystemsC$22.42M1.96C$3.72MC$0.0310.67
BriaCell TherapeuticsN/AN/AN/A-C$0.38-28.19

Summary

Microbix Biosystems beats BriaCell Therapeutics on 11 of the 11 factors compared between the two stocks.

Get Microbix Biosystems News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBX vs. The Competition

MetricMicrobix BiosystemsBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$43.97MC$138.93MC$5.17BC$5.46B
Dividend Yield2.30%3.49%2.76%5.58%
P/E Ratio10.67201.8598.2220.83
Price / Sales1.9619,266.742,389.702,548.93
Price / Cash4.1311.5335.4179.75
Price / Book1.607.225.543.54
Net IncomeC$3.72M-C$20.82MC$106.07MC$287.78M
7 Day PerformanceN/A1.26%1.14%-0.16%
1 Month Performance-5.88%4.85%0.69%2.59%
1 Year Performance-18.99%5.59%2.66%29.08%

Microbix Biosystems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BCT
BriaCell Therapeutics
0 of 5 stars
C$10.60
-3.8%
N/A+0.0%C$168.68MN/A-28.195
IPA
ImmunoPrecise Antibodies
0 of 5 stars
C$6.50
+0.8%
N/A+0.0%C$162.08MC$19.47M-7.3073Gap Down
SVA
Sernova
1.0779 of 5 stars
C$0.37
+12.1%
C$1.50
+305.4%
-54.9%C$112.26MN/A-2.851,959Gap Down
ONC
Oncolytics Biotech
0.4274 of 5 stars
C$1.46
-0.7%
C$3.00
+105.5%
-34.8%C$110.11MN/A-3.6529
SCYB
Scythian Biosciences
0 of 5 stars
C$3.49
-5.9%
N/A+0.0%C$102.38MN/A0.00N/AHigh Trading Volume
COM
138267 (COM.TO)
0 of 5 stars
N/AN/AN/AC$102.19MN/A0.00N/A
NVH
Novoheart
0 of 5 stars
C$0.53
+1.9%
N/A+0.0%C$99.98MC$423,500.00-13.95N/A
IGX
IntelGenx Technologies
0 of 5 stars
C$0.58
+1.8%
N/A+0.0%C$87.32MC$1.75M-7.4448Gap Up
TH
Theratechnologies
0.8535 of 5 stars
C$1.71
-1.2%
C$5.50
+221.6%
+47.4%C$78.63MC$78.10M-2.16103
PDP
Pediapharm
0 of 5 stars
C$0.30
+1.7%
N/A+0.0%C$66.36MC$11.16M-4.11N/A

Related Companies and Tools

This page (TSE:MBX) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners